SCHEMBL1630601

SCHEMBL1630601

O=C(O)c1cccc(CCc2cc(-c3ccnn3-c3ccccc3Cl)c(O)cc2O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.63
PTGER1 P34995 1/20 0.45
KDM4C Q9H3R0 5/20 0.42
KDM5A P29375 4/20 0.42
KDM5B Q9UGL1 4/20 0.42
PRKAG1 P54619 2/20 0.39
PRKAA2 P54646 2/20 0.39
PRKAB1 Q9Y478 2/20 0.39
NR3C2 P08235 1/20 0.39
SLC16A3 O15427 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
MITF O75030 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
XBP1 P17861 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630555 0.89 HSP90AA1 (0.74) HSP90AA1PTGER1KDM4CKDM5AKDM5B
SCHEMBL1629523 0.84 PTGER1 (0.48) HSP90AA1PTGER1KDM4CKDM5AKDM5B
SCHEMBL1630033 0.83 HSP90AA1 (0.72) HSP90AA1KDM4CKDM5AKDM5BNR3C2
SCHEMBL1630023 0.82 HSP90AA1 (0.58) HSP90AA1NR3C2POLB
SCHEMBL1630516 0.82 HSP90AA1 (0.70) HSP90AA1KDM4CKDM5AKDM5BNR3C2
SCHEMBL1628956 0.79 HSP90AA1 (0.73) HSP90AA1NR3C2SMN1; SMN2
SCHEMBL1630240 0.79 HSP90AA1 (0.72) HSP90AA1NR3C2MEN1KMT2ANPC1
SCHEMBL1629245 0.78 HSP90AA1 (1.00) HSP90AA1NR3C2SLC16A3KMT2ANPC1
SCHEMBL1629156 0.77 HSP90AA1 (0.67) HSP90AA1NR3C2MEN1KMT2A
SCHEMBL1629661 0.77 HSP90AA1 (0.65) HSP90AA1KDM4CKDM5AKDM5BNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP claimed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885PTGER1 1113/4885KDM4C 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.